跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BRIVIACT brivaracetam 10mg/mL oral solution bottle - TGA Drug Approval Details
Approvals
/
TGA
/
BRIVIACT brivaracetam 10mg/mL oral solution bottle
Approved
STANDARD
BRIVIACT brivaracetam 10mg/mL oral solution bottle
UCB Australia Pty Ltd T/A UCB Pharma Division of UCB Australia
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
516ee9ab604eaeaf
Company
UCB Australia Pty Ltd T/A UCB Pharma Division of UCB Australia
Type
Standard
Approval Details
Approval Id
516ee9ab604eaeaf
Product Name
BRIVIACT brivaracetam 10mg/mL oral solution bottle
Artg Id
243793
Artg Name
BRIVIACT brivaracetam 10mg/mL oral solution bottle
Sponsor
UCB Australia Pty Ltd T/A UCB Pharma Division of UCB Australia
Company Detail Path
/organization/ucb-australia-pty-ltd
Artg Date
2016-08-04
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2016-CMI-02362-1
Product Information
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2016-PI-02359-1
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
516ee9ab604eaeaf
Type
Standard
Back to TGA Approvals